Previous close | 6.60 |
Open | 6.45 |
Bid | 6.50 x N/A |
Ask | 6.70 x N/A |
Day's range | 6.40 - 6.50 |
52-week range | 3.64 - 34.60 |
Volume | |
Avg. volume | 2 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Q2 2024 Outlook Therapeutics Inc Earnings Call
13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities.